RTI becomes a pure spine company after selling OEM business off (60% of total business) to PE for $490M (2.5 X Sales)

websites - RTI Surgical Montagu

RTI Surgical Holdings, Inc.® Announces Sale of OEM Business and Preliminary Fourth Quarter and Full Year 2019 Revenues (press release) Subsequent to Closing of the $490M Transaction, RTI Surgical Will Be a Global Pure Play Spine Company Targeting Double-Digit Growth DEERFIELD, Ill., Jan. 13, 2020 (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (RTIX), a global surgical implant company, today announces a definitive agreement for the sale of the Company’s OEM business to Montagu Private Equity LLP (‘Montagu’), a leading European private equity firm, for a total consideration of $490 million. The transaction is targeted to close in the first half of 2020. Transaction Overview

RTI Surgical Holdings has agreed to sell its OEM business to Montagu, a leading European private equity firm, for $480 million in cash and certain other consideration, totaling $490 million  The RTI Surgical Holdings Board of Directors unanimously approved the transaction  The transaction is subject to approval from RTI Surgical Holdings’ shareholders, the customary regulatory approvals and the satisfaction of customary closing conditions, and is targeted to clos...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top